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In recent years, core-shell nanofibrous drug delivery systems have received increasing 39 
attention due to their ability to incorporate two or more active pharmaceutical ingredients 40 
(APIs) individually into the desired layer (either core or sheath) and thereby finely tune the 41 
release profiles of even incompatible drugs in one system. This study aims to perform 42 
formulation and solid-state characterisation of levofloxacin-loaded polylactic acid (PLA) - 43 
naproxen-sodium-loaded polyvinyl pyrrolidone (PVP) bicomponent core-shell fibrous sheets 44 
and examine the electro spinnability of the precursor combinations. The selected drugs have 45 
potential therapeutic relevance in similar systems intended for wound healing; however, in 46 
this study, they are used as model drugs to understand the physicochemical properties of a 47 
drug loaded system. In order to determine the best core- and shell-solution combination, a full 48 
factorial experimental design is used. A combination of various morphological (scanning 49 
electron microscopy and transmission electron microscopy) and microstructural 50 
characterisation techniques (X-ray photoelectron spectroscopy and Raman spectroscopy) was 51 
applied to non-invasively obtain information about the structure of the fibres and the 52 
embedded drugs. The results indicate that core-shell fibres of different compositions could be 53 
successfully prepared with various structural homogeneities. The best core-shell structure was 54 
obtained using a combination of 15% (w/w) shell concentration and 8% (w/w) PLA solution 55 
concentration. In addition to the conventional core-shell structural verification methods, the 56 
Raman spectroscopy method was implemented to reveal not only the core-shell structure of 57 
the PLA/PVP nanofibers but also the form of the embedded drugs. The Raman mapping of 58 
the fibres confirm the above results, and it is shown that an amorphous solid dispersion is 59 





1. Introduction 63 
Electrospinning is a well controllable, relatively simple, and cost-effective technique for the 64 
preparation of matrices with nano-and micrometre-sized fibres (Pelipenko et al., 2015; Smith 65 
and Ma, 2004; Xue et al., 2019). Owing to the unique properties of fibrous materials, such as 66 
the high porosity with an interconnected pore network and the large surface area of fibrous 67 
sheets, they can be embedded together with active pharmaceutical ingredients (APIs) into a 68 
polymeric matrix carrier in an amorphous state. This could lead to increased dissolution, 69 
which increases the bioavailability of drugs with lower solubility (Huang et al., 2003).  70 
Nano- and micro fibrous materials have a unique structure, vast material variety, and the 71 
potential for multifunction and mass production; therefore, they are widely used with 72 
nanofibrous scaffolds, which are loaded with different drugs or drug combinations, as drug 73 
delivery systems for tissue engineering and wound bandage (Barnes et al., 2007; Haider et al., 74 
2018). These materials are widely used in biomedical applications as they have similar 75 
features and morphologies as that of the extracellular matrix, which is the non-cellular 76 
component that is present within all tissues and organs and plays a crucial role in the wound 77 
healing process (Liu et al., 2017). Therefore, materials that can mimic their structure and 78 
stimulate cell proliferation can help in wound healing (Rieger et al., 2013). Zahra et al. 79 
reported that a core–shell structure could provide a more controlled release of a model biocide 80 
with prolonged antibacterial properties than single nanofibers. These nanofibrous mats have 81 
the potential to selectively release antibacterial agents to prevent wound infections without 82 
delaying wound healing (Abdali et al., 2019). 83 
However, the diverse field of applications requires adequate functionality-related 84 
characteristics. In order to fulfil the numerous quality and functionality requirements of 85 
fibrous scaffolds, a multicomponent core-shell fibrous structure has been developed. It can 86 
provide additional unique and essential properties that are relevant for biomedical applications 87 
(Elahi et al., 2013). The core polymer/composite ensures features that are required for tissue 88 
regeneration. At the same time, the shell material protects the unstable APIs embedded into 89 
the core from unfavourable environmental effects. This improves the hydrophilicity and 90 
biocompatibility of the fibrous samples (Elahi et al., 2013; Han and Steckl, 2019). One of the 91 
significant advantages of these core-shell nanostructures is the ability to tailor the release 92 
properties of the incorporated drug, which is easily achieved by the careful choice of the drug-93 
polymer-solvent (or solvent mixture) precursor system (Huang and Thomas, 2018; Jiang et 94 
 
 
al., 2005). Basically, the core-shell fibrous structure provides four directions for improving 95 
polymer-based nanofibrous drug delivery systems (Han and Steckl, 2019): 96 
(1) Combining two or more polymers or polymer compositions in a single fibre 97 
provides the required biocompatibility and mechanical properties. 98 
(2) By incorporating the drug into the core and covering it with the shell, a sustained 99 
release of the drug can be achieved. 100 
(3) Two or more APIs can be incorporated individually into the desired layer (either 101 
the core or the sheath), which enables controlled release of the embedded drugs. 102 
(4) Trigger release or external stimuli-responsive controlled release (Han and Steckl, 103 
2019). 104 
Although the basics of the production of core-shell type nanofibers are known in the 105 
literature, the development of a new core-shell system is still challenging. Several drug 106 
combinations have been incorporated into various polymer-based core-shell fibres; however, a 107 
technique for verifying the core-shell structure has not been studied in detail yet. In a few 108 
studies, the structure was verified using scanning electron microscopy (SEM) measurements 109 
(Huang and Thomas, 2018; Khalf et al., 2015). However, it should be noted that SEM can be 110 
a useful tool to verify the core-shell structure of the fibres only if the core component can be 111 
selectively extracted (Wang et al., 2010). 112 
The typical and conventional core-shell structure characterisation technique is the use of 113 
transmission electron microscopy (TEM), which is capable of detecting materials with 114 
different densities. This technique is primarily applicable in cases where different materials 115 
are used for the core and shell. However, it is also possible to make a core-shell fibrous 116 
sample using the same polymer as core and sheath materials. Nevertheless, this method is less 117 
applicable in this case, because the difference in density is rather small as they are caused 118 
only by the APIs (Alharbi et al., 2018; Chen et al., 2010; Pakravan et al., 2012; Sun et al., 119 
2003; Zhang et al., 2004).  120 
Atomic force microscopy (AFM) has also been used to verify the structure. However, its 121 
applicability depends on the observation of the surface morphologies of single needle 122 
electrospun samples and the coaxial electrospun scaffold and even on the 123 
mechanomanipulation of the force spectroscopy. Nevertheless, for this measurement, it is 124 
essential to have a sample of the sparse surface coverage with minimal overlap between the 125 
fibres, and only those parts of the sample that lie completely on the disc can be examined 126 
(Chen et al., 2015; Kazsoki et al., 2018; Zander et al., 2011). 127 
 
 
Another novel non-invasive technique is Raman mapping, which can provide structural and 128 
quantitative information of the fibres by monitoring selective peaks of the polymers and the 129 
APIs (if their concentrations are large enough). This technique is suitable for tracking the 130 
physical state of the embedded drugs (Farkas et al., 2015; Sfakis et al., 2017; Sharikova et al., 131 
2020). However, due to its limitations with regard to resolution, it can be used effectively 132 
only in the case of fibres with larger diameters (close to or over a micrometre). 133 
This study aims to prepare levofloxacin-loaded polylactic acid (PLA) - naproxen-sodium-134 
loaded poly(vinylpyrrolidone) (PVP) bicomponent core-shell fibrous sheets and examine the 135 
electro spinnability of the precursor combinations. The selected APIs have a potential 136 
therapeutic relevance in wound healing; however, in this study, these molecules are used as 137 
model drugs to understand the physicochemical properties of a drug-loaded core-shell fibre 138 
based system. A full factorial experimental design (of two factors in three levels) was used to 139 
determine the best combination of the drug-loaded core (PLA) and shell (PVP) viscous 140 
solutions for coaxial electrospinning. A combination of conventional (such as TEM and XPS) 141 
and novel morphological and solid-state characterisation methods (such as Raman 142 
spectroscopy) was applied to simultaneously monitor the core-shell structure and the form of 143 
actives embedded into the core and shell polymers. The study investigates the best 144 
composition with excellent fibre structure characteristics for potential application in chronic 145 
wound healing (Fig. 1). 146 
 147 




2. Materials and methods 150 
2.1. Materials 151 
Levofloxacin ((S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-7H-152 
pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid) >98%, M=361.37 g mol
-1
) and 153 
naproxen-sodium ((S)-6-Methoxy-α-methyl-2-naphthaleneacetic acid sodium salt, >98%, M = 154 
252.24 g mol
-1
), which were obtained commercially from Sigma-Aldrich (Budapest, 155 
Hungary), were used as the APIs. Polylactic acid (PLA, GF45989881, Mw~ 85000-160000 g 156 
mol
-1
 nominal granule size of 3-5 mm, density 1.24 g cm
-3
) was chosen as the base of the core 157 
part of the fibres, and poly(vinyl pyrrolidone) (PVP, Kollidon K90, average Mw ~ 1500000 g 158 
mol
-1
) was chosen as the shell polymer; both of them were obtained from Sigma-Aldrich 159 
(Budapest, Hungary). Hydroxypropyl-beta-cyclodextrin (average degree of substitution (n) ~ 160 
4.5, (1135.0 + n*58.1) g mol
-1
) was purchased from Cyclolab Ltd. (Budapest, Hungary). 161 
Polysorbate 80 was purchased from Molar Chemicals (Budapest, Hungary). Absolute ethanol 162 
(Molar Chemicals, Budapest, Hungary) and distilled water were used to prepare the shell 163 
electrospinning precursor. As a solvent of the viscous solution of the core, chloroform 164 
(anhydrous grade, containing amylenes as stabilisers, >99%, Sigma Aldrich, Budapest, 165 
Hungary) and N,N-dimethylformamide (DMF, anhydrous grade, 99.8%, Sigma Aldrich, 166 
Budapest, Hungary) were used. The materials were used without further purification. 167 
 168 
2.2. Preparation of polymer precursors for electrospinning experiments 169 
In this study, PLA and PVP were chosen as the polymers for the core and sheath components, 170 
respectively.  171 
Since the use of a precursor solution has a significant impact on the success of the 172 
electrospinning process and the morphology of the prepared samples, preliminary experiments 173 
were performed to determine the optimal composition of the viscous polymer solutions used 174 
for the shell and core formation. Therefore, the concentrations of the polymer solutions, 175 
applied solvent mixture, and other additives (the polysorbate 80) were determined. 176 
Water: ethanol 8:2 (m:m) was used for the shell solution and chloroform: DMF 6:1 (m:m) 177 
solvent was used for the core solution. The previous experiment revealed that when the PLA 178 
concentration is less than 7% (w/w), single-needle electrospinning does not result in bead-179 
free, continuous fibres. 180 
Naproxen-sodium-loaded PVP solutions and levofloxacin-loaded PLA solutions were 181 
prepared by using the appropriate composition and solvent mixture under magnetic stirring 182 
until a clear, viscous solution was obtained. Both the core and sheath solutions contained 183 
 
 
0.5% (w/w) polysorbate 80. The sheath solutions contained 2% (w/w) non-steroidal anti-184 
inflammatory drug and 14% (w/w) HP-β-CD. The levofloxacin concentration of the core 185 
solution was adjusted to 0.5% (w/w).  186 
A full factorial design of the experiment was used to optimise the fibre composition. The two 187 
factors were the core- and shell-polymer solution concentrations, and each factor was 188 
examined at three levels. Only the polymer concentration differed between the solutions. 189 
Based on the preliminary single-needle electrospinning experiments, the PLA concentration 190 
(factor 1) was chosen as 7%, 8%, and 9% (w/w), while the PVP concentration (factor 2) was 191 
chosen as 14%, 15%, and 16% (w/w) (Table 1).  192 
Table 1 Design of experiments (DoE) indicating the various electrospun samples 193 
sample  factor 1 
level −1 level 0 level +1 
 
factor 2 
level −1 CS_1 CS_2 CS_3 
level 0 CS_4 CS_5 CS_6 
level +1 CS_7 CS_8 CS_9 
 194 
2.3. Coaxial electrospinning 195 
A lab-scale coaxial electrospinning equipment (SpinSplit Ltd., Budapest, Hungary) was used 196 
for preparing the fibre. Homogenous precursor solutions were placed in plastic syringes (Luer 197 
lock syringe, Sigma Aldrich Ltd., Budapest, Hungary), which were connected to conventional 198 
(22 gauge) or coaxial (inner needle: 22 gauge and outer needle: 18 gauge) emitters using 199 
Teflon tubing. Pump systems were used to provide a continuous feeding rate, which was 0.08 200 
µl/s for the core solution and 0.2 µl/s for the shell solution. The applied voltage was 10 – 25 201 
kV, and the emitter to collector distance was set between 10 – 20 cm. Finally, the best fibre 202 
characteristic was achieved when the applied voltage was 15 ± 0.5 kV and the emitter to 203 
collector distance was 20 cm. 204 
The samples were collected on a grounded aluminium plate covered with aluminium foil. 205 
During the electrospinning process, the formation of Taylor cone and its stability were 206 
monitored using the camera system of the equipment. This helped in identifying the best 207 
process parameters. The electrospinning experiments were performed in a well-controlled 208 
room having an ambient temperature of 22 ± 1 °C and a relative humidity of 50 ± 5%. 209 
 210 
2.4. Scanning electron microscopy (SEM) 211 
The samples were fixed using a conductive double-sided carbon adhesive tape and then 212 
coated with a gold layer (JEOL JFC-1200 Fine Coater, JEOL Ltd., Tokyo, Japan). SEM 213 
 
 
images were taken with a JEOL JSM-6380LA scanning electron microscope (JEOL Ltd., 214 
Tokyo, Japan). The acceleration voltage and the working distance were 15 kV and 10 mm, 215 
respectively. 216 
 217 
2.5. Transmission Electron Microscopy (TEM) 218 
The core-shell structure of the coaxially electrospun nanofibers were examined on a JEOL 219 
JEM-2100F transmission electron microscope operated at 200 kV. The samples for the TEM 220 
analysis were prepared by directly depositing the as-spun nanofibers on a carbon grid (Agar 221 
Scientific) followed by fixing with a methanol drop. The TEM images were recorded using a 222 
charge-coupled device (CCD) camera controlled via Gatan DigitalMicrograph
®
 software.  223 
 224 
2.6. X-ray Photoelectron Spectroscopy (XPS) 225 
In order to determine the chemical composition of the surface of the samples (<5 – 10 nm), 226 
XPS measurements were carried out using a Kratos Axis Ultra instrument with an Al Kα1 X-227 
ray source (hυ = 1486.7 eV). Core-shell fibres, which were electrospun onto an aluminium 228 
foil, were used for the XPS analysis. Wide energy survey scans (WESS) were performed for 229 
samples over a binding energy of 0 – 1205 eV and pass energy of 160 kV.  230 
Using the survey-scan spectrum, the surface elemental compositions relative to carbon was 231 
calculated from the peak area with a correction for atomic sensitivity. The XPS spectra were 232 
analysed using CasaXPS software. The quantification peaks were fitted using the mixed 233 
Gaussian-Lorentzian (GL30) function after performing Shirley background correction. 234 
 235 
2.7. Raman microscopy measurements 236 
The Raman spectroscopy measurements were carried out using a LabRAM system (Horiba 237 
Jobin-Yvon, Lyon, France) coupled with an Olympus BX-40 optical microscope (Olympus, 238 
Hamburg, Germany) and a 532 nm Nd:YAG laser source (Sacher Lasertechnik, Marburg, 239 
Germany). For optical imaging, objectives of 20x and 100x magnifications were used. 240 
A monochromator and a CCD detector were used for the dispersion and detection of Raman 241 
photons, and an intensity filter (D = 0.3) was applied during the measurements. The data was 242 
collected and processed using Labspec 5 software. 243 
During the measurements of the reference samples (active pharmaceutical ingredients, 244 
polymers, cyclodextrin, and polysorbate), the 20x objective was used. First, the spectra were 245 
collected over a comprehensive spectral range of 100 – 2000 cm
-1
, so that the spectral range 246 
where most of the relevant signals of the fibrous samples are detected can be selected later 247 
 
 
during the final measurement. Finally, the spectral range of 346 – 1790 cm
-1
 was selected as 248 
the most suitable range for data acquisition, and for this, an optical grating of 1800 249 
groove/mm was set to 1100 cm
-1
. The resolution was 5 cm
-1
. For some components, 250 
fluorescence interference with different levels were observed, and they were removed by 251 
baseline correction.  252 
Considerable differences were observed between the Raman activities of the individual 253 
components. In the case of the crystalline drugs, an acquisition time of 2 s was sufficient to 254 
achieve intensities of ten thousand times, while 8 – 30 s was required for the excipients to 255 
provide an excellent signal to noise ratio. For the measurements of the fibrous sample, the 256 
100x objective was used. 257 
Single fibres were suitable for the Raman analysis; the different nanofibrous samples 258 
(placebo- and drug-loaded fibres) were electrospun for 3 – 4 s on a glass microscope slide 259 
covered by an aluminium foil. These samples were investigated without any further sample 260 
preparation.  261 
For the spatial distribution measurements, vertical fibres in the Y direction were chosen. They 262 
were monitored by systematically moving the motorised stage along the X direction. Each 263 
map was collected with a step size of 0.1 µm. For the evaluation, the spectra of the placebo 264 
and drug-loaded fibres prepared by single-needle electrospinning were used. 265 
The mapped spectra as well as the reference spectra were corrected by fitting the linear 266 
baseline through specified points; all the spectra were normalised in terms of the area. 267 
 268 
 269 
3. Results and discussion 270 
3.1 Morphological characterisation 271 
SEM was used to investigate the morphology of the sample prepared by coaxial 272 
electrospinning. SEM images of the electrospun samples show that randomly oriented fibrous 273 
structures without beads and film-like elements having submicron fibre diameter were 274 
obtained (Fig. 2). There were no significant differences between the densities of the fibres in 275 




Fig. 2 SEM images of coaxially electrospun samples: 278 
CS_1 (A), CS_2 (B), CS_3 (C), CS_4 (D), CS_5 (E), CS_6 (F), CS_7 (G), CS_8 (H), and 279 
CS_9 (I) 280 
 281 
3.2 Structural investigation 282 
The core-shell structure of the electrospun samples was investigated via TEM measurements. 283 
Fig. 3 shows the TEM micrographs of the core-shell structure of the composite ultrafine 284 
fibres. It was found that for the samples coded CS_4, CS_5, CS_6, and CS_7 (shown in Fig. 3 285 
D, E, F, and G, respectively), the diameter of the core structure was uniform throughout the 286 
fibre, evidencing a sharp core-shell interface for all the samples analysed. According to 287 
previous studies, this implies that the core and shell materials have different electron 288 
transmission abilities (Zhang et al., 2006). In addition, the sharp boundaries are associated 289 
with the fast processing characteristic of electrospinning, which prevents mixing between the 290 
core solution and shell solution (Chen et al., 2010; Sun et al., 2006). For the samples based on 291 
14% PVP and 16% PVP with a core concentration of 8% and 9% PLA, the core-shell 292 
structure was irregular, with an evident effect on the resulting fibre morphology (Fig. 3 A, B, 293 
C, H, and I). This could be attributed to the fact that the core fluid jetting out of coaxial 294 
 
 
capillaries might be split into a number of sub-jets during the electrospinning process (Xue et 295 
al., 2019).  296 
 297 
 298 
Fig. 3 TEM images of coaxially electrospun samples: 299 
CS_1 (A), CS_2 (B), CS_3 (C), CS_4 (D), CS_5 (E), CS_6 (F), CS_7 (G), CS_8 (H), and 300 
CS_9 (I)  301 
 302 
3.3 Surface characterisation of the fibrous samples 303 
The elemental composition on the surface of the PVP/PLA core-shell electrospun nanofiber 304 
was characterised via XPS. Fig. 4 shows the WESS from all the core-shell samples. As 305 
expected, the coaxial electrospun meshes showed very similar spectra across different 306 
samples; they were characterised by four peaks corresponding to C1s (binding energy: 286 307 
 
 
eV), N1s (binding energy: 400 eV), O1s (binding energy: 532 eV), and Na1s (binding energy: 308 
1072 eV). This suggests consistent composition of the shell in all the samples. Moreover, the 309 
XPS data does not show any F and Cl signal on the PVP nanofiber surface. Since XPS 310 
elemental analysis can detect the characteristics of a specimen at a maximum depth of ~100 Å 311 
(Sun et al., 2002), the absence of F 1s and Cl 2p peaks on the XPS spectra of the nanofiber 312 
surfaces indicates the following: 313 
i) The shell thickness is at least beyond the ultimate detection depth of XPS (i.e., 5 –314 
10 nm). 315 
ii) There is good interfacial stability between the inner and outer solutions. 316 
iii) The electrospinning process is effective (Sun et al., 2002). 317 
 318 
 319 
Fig. 4 XPS survey scan spectra from the coaxially produced nanofiber samples: CS_1 (A), 320 
CS_2 (B), CS_3 (C), CS_4 (D), CS_5 (E), CS_6 (F), CS_7 (G), CS_8 (H), and CS_9 (I)  321 
 in the 0 – 1200 eV range 322 
 323 
3.4 Raman mapping 324 
Besides the verification of the desired structure, investigation of the physical state of the 325 
embedded drugs has a significant impact on the drug delivery system, because it affects the 326 
 
 
drug release as well as the short- and long-term stability of the final dosage. Raman mapping 327 
is a useful method for analysing these. Based on the TEM results, the three best compositions 328 
were selected for further analysis using Raman spectroscopy, in which the effect of factor 1 is 329 
examined. 330 
Fig. 5 shows the Raman spectra of the active pharmaceutical ingredients, namely the placebo-331 
and drug-loaded samples. Although in the case of the fibrous samples, lower intensities could 332 
be observed compared to the initial materials, the recorded spectra of the fibrous samples did 333 
not differ considerably, which suggests that the fibre formations had little influence on the 334 
shape of the spectra of the polymers. 335 
 It can be seen that there is a small difference between the spectra of the crystalline drugs and 336 
the drug-loaded fibres. In the latter case, fewer and weaker drug signals could be observed. 337 
The broadening and merging of the spectra could be related to the fact that the drugs were 338 
incorporated into the fibres in an amorphous state. In the case of the levofloxacin-loaded 339 
fibrous sample, the most visible changes in the peak can be observed at 496, 518, 1555, 1621, 340 
and 1658 cm
-1
, while naproxen made significant contributions to the signals of the polymeric 341 




Fig. 5 Raman spectra of the model drugs, namely the placebo- and drug-loaded core- and 344 
shell nanofibers prepared by single-needle electrospinning: levofloxacin (A), placebo core 345 
nanofiber (B), levofloxacin-loaded core nanofiber (C), naproxen-Na (D), placebo shell 346 




A novel Raman mapping method was used to confirm the core-shell structure by monitoring 349 
selected polymer signals of the spectra. For the evaluation, single core and shell fibre 350 
reference spectra were used, and the spectral concentrations were calculated using the 351 
classical least squares (CLS) method with a spectral range of 346 – 1790 cm
-1. 
 352 
The Raman maps show the contributions of the polymer components in the fibres (Fig. 6). 353 
The spectral concentration of the polymer components was normalised to 100%. The green 354 
represents the spectral concentration of the core polymer (PLA), while the red line represents 355 
that of the shell polymer (PVP). 356 
The signals from the edge of the fibre came only from the shell polymer, while the signals 357 
from the centre part (of the 2D projection of the fibre) included contributions from both the 358 
polymers, which is indicative of the core-shell structure of a single coaxially electrospun 359 




Fig. 6 Raman spectra from the core-shell fibrous samples 362 
(A:CS_4, B: CS_5, C:CS_6) 363 
 364 
5. Conclusion 365 
Levofloxacin-loaded polylactic acid (PLA) - naproxen-sodium-loaded poly(vinylpyrrolidone) 366 
(PVP) bicomponent core-shell fibrous sheets were formed from precursors of different 367 
concentrations according to a full factorial DoE to optimise the fibre composition. The SEM 368 
measurements indicated that each of the nine examined core-shell precursor combinations 369 
enabled the formation of clear fibrous mats. The conventional fibre-structure characterisation 370 
(e.g. TEM) indicated that core-shell fibres of different compositions were successfully 371 
prepared with various structural homogeneities. The XPS spectra of the nanofiber surfaces 372 
indicated excellent interfacial stability between the inner and outer polymer solutions. The 373 
 
 
best sample was achieved with the combination of 15% (w/w) shell concentration and 8% 374 
(w/w) PLA solution concentration. In addition to the conventional core-shell structural 375 
verification methods, the Raman spectroscopy method was successfully applied to reveal the 376 
core-shell structure of the PLA/PVP nanofibers. The spatial distributions of the polymers 377 
were found to be different for different sampling points. In addition, the formation of 378 
amorphous solid dispersions was observed. 379 
Core-shell fibrous materials have been successfully prepared in various studies using 380 
numerous polymer combinations; however, there is no universal morphological 381 
characterisation method for structure verification. With regard to the characterisation of the 382 
structure of coaxially electrospun samples, it is very important to consider the properties of 383 
the polymers used when selecting the characterisation method. A combination of several 384 
methods may be required to obtain information about the structure. Although it has certain 385 
limitations, Raman mapping could be a universal method for fibre structure determination, 386 
especially since it can obtain information about the distribution of the drug when the 387 
concentration of the embedded drugs in the fibre is large. This could be the subject of future 388 
research. 389 
 390 
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